Morphological alterations in the spleen of rats during late stages of experimental streptozotocin-induced diabetes mellitus

Authors

DOI:

https://doi.org/10.26641/1997-9665.2024.4.95-100

Keywords:

diabetes mellitus, spleen, morphological changes, immune system.

Abstract

Background. Diabetes is a systemic disease that affects various organs and systems of the body. One of the known complications is damage to the immune system. However, changes in the spleen, as the central organ of the immune system in diabetes, have not been studied sufficiently. Objective. To study the features of morphological changes in the spleen in the late stages of experimental diabetes mellitus. Methods. The article presents the results of an experimental study of changes in the spleen parenchyma of rats with streptozotocin diabetes. The study was conducted on 11 adult white male rats, which were divided into two groups: control and experimental. Diabetes mellitus was induced by a single intraperitoneal injection of streptozotocin. Spleens were harvested 42 days and 56 days after induction of diabetes mellitus. Results. In diabetic rats, a sharp decrease in the mean diameter of lymphoid nodules was observed: (360.9±10.5) μm after 42 days and (314.64±11.98) μm after 56 days, compared with (448.06±9.68) μm in the control group (p<0.05). The diameters of periarteriolar lymphoid sheths also differed significantly in different groups: the average diameter was 31.41% smaller in diabetic rats (p<0.01). The narrowing of the central artery lumen probably led to pathological changes in the lymphoid structures of the spleen in diabetes. Conclusion. Significant morphological changes were observed in the red and white pulp of the rat spleen in the late stages of experimental streptozotocin-induced diabetes mellitus. The obtained results demonstrate a substantial impact of experimental diabetes on the structural elements of the rat spleen, with progressive changes manifesting at both time points, more prominently at 56 days of streptozotocin-induced diabetes mellitus.

References

  1. International Diabetes Federation: IDF Diabetes Atlas. 10th. Brussels (Belgium): International Diabetes Federation; 2021.
  2. Ferlita S, Yegiazaryan A, Noori N, Lal G, Nguyen T, To K, et al. Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially Mycobacterium tuberculosis. Journal of Clinical Medicine. 2019;8(12):2219. DOI: 10.3390/jcm8122219
  3. Tang L, Wang H, Cao K, Xu C, Ma A, Zheng M, et al. Dysfunction of circulating CD3+CD56+ NKT-like cells in type 2 diabetes mellitus. International Journal of Medical Sciences. 2023;20(5):652–662. DOI: 10.7150/ijms.83317
  4. Aliyu M, Zohora F, Saboor-Yaraghi AA. Spleen in innate and adaptive immunity regulation. 2021;5(1):1–17. DOI: 10.3934/ALLERGY.2021001
  5. Kolling J, De Franceschi ID, Nishihira VSK, Baldissera MD, Pinto CG, et al. Resveratrol and resveratrol-hydroxypropyl-β-cyclodextrin complex recovered the changes of creatine kinase and Na+, K+-ATPase activities found in the spleen from streptozotocin-induced diabetic rats. Anais Da Academia Brasileira De Ciências. 2019;91(3):e20181330. DOI: 10.1590/0001-3765201920181330
  6. Levytskyi VA, Zhurakivska OYa, Miskiv VA, Zaiats LM, Petriv RB, Yakymiv YuM, Kishchuk BM, Gnatyuk RZ, inventors; Sposib modeliuvannia tsukrovoho diabetu 1-ho typu u tvaryn riznoho viku. Method of modeling type 1 diabetes in animals of different ages. Ukrainian patent UA 62966 U. 2011 Feb 11. Int. CI. A61B10/00. IPC G09B23/28 №u201101566. Filed 2011. Published Sep
  7. Michael X Henderson. Hematoxylin and Eosin Stain - FOR PARAFFIN-EMBEDDED TISSUE SECTIONS 2023;1:86. doi: 10.17504/protocols.io.kxygx3q9zg8j/v1
  8. Kunzmann P, Hamacher K. Biotite: a unifying open source computational biology framework in Python. BMC Bioinformatics. 2018;19(1):346. DOI: 10.1186/s12859-018-2367-z
  9. Hossam Ebaid, Jameel Al-Tamimi, Ali Metwalli, Ahmed A, Allam, Kairy Zohir, Jamaan S, Ajarem, Ahmed Rady, Ibrahim M, Alhazza, Khalid E, Ibrahim. Effect of STZ-Induced Diabetes on Spleen of Rats: Improvement by Camel Whey Proteins. Pakistan Journal of Zoology. 2015;Vols.47-4:1109–1116.
  10. Bhatwa A, Anhê G, Anhê F, Schertzer J. Does Obesity or Hyperglycemia Alter Metabolic Endotoxemia? Physiology. 2023;38(1):5729581. DOI: 10.1152/physiol.2023.38.s1.5729581
  11. Rodrigues Mantuano N, Stanczak MA, Oliveira I de A, Kirchhammer N, Filardy AA, Monaco G, et al. Data from Hyperglycemia Enhances Cancer Immune Evasion by Inducing Alternative Macrophage Polarization through Increased O-GlcNAcylation. American Association for Cancer Research. 2020;8(10):1262–1272. DOI: 10.1158/2326-6066.c.6549885.v1
  12. Wang Y, Yi B, Wang S, Chen X, Wen Z. Effect of hyperglycemia on the immune function of COVID-19 patients with type 2 diabetes mellitus: a retrospective study. PeerJ. 2022;10:e14570. DOI: 10.7717/peerj.14570
  13. Chen B, Zhang H, Liu Y. The Correlation Study of Hyperglycemia on the Expression of White Blood cells and Inflammatory Genes in Patients with Type 2 Diabetes. International Journal of Frontiers in Medicine. 2021;3(3):5-10. DOI: 10.25236/ijfm.2021.030302
  14. Szukiewicz D. Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity. International Journal of Molecular Sciences. 2023;24(12):9818-9818. doi: 10.3390/ijms24129818
  15. Dri E, Lampas E, Lazaros G, Lazarou E, Theofilis P, Tsioufis C, et al. Inflammatory Mediators of Endothelial Dysfunction. Life. 2023;13(6):1420. DOI: 10.3390/life13061420
  16. Li T, Wang P, Wang X, Liu Z, Zhang Z, Zhang Y, et al. Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients. Nutrients. 2023;15(12):2808. DOI: 10.3390/nu15122808
  17. Zhang J, Deng Z, Jin L, Yang C, Liu J, Song H, et al. Spleen-Derived Anti-Inflammatory Cytokine IL-10 Stimulated by Adipose Tissue-Derived Stem Cells Protects Against Type 2 Diabetes. Stem Cells and Development. 2017;26(24):1749–1758. DOI: 10.1089/scd.2017.0119
  18. Özerkan D, Özsoy N, Cebesoy S, Özer Ç. Distribution of spleen connective tissue fibers in diabetic and vitamin C treated diabetic rats. Biotechnic & Histochemistry. 2020;96(5):347–353. DOI: 10.1080/10520295.2020.1795718
  19. Hashish H, Kamal R. Effect of curcumin on the expression of Caspase-3 and Bcl-2 in the spleen of diabetic rats. Journal of Experimental and Clinical Anatomy. 2015;14(1):18-23. DOI: 10.4103/1596-2393.158923
  20. Unissa N, Mahveen M, Kumar S, Katla Swapna. An observation cross sectional study to assess the prevalence of microvascular complications in diabetes. International Journal of Hospital Pharmacy. 2019;4:31.
  21. Ravshanovna NSD. Morphological Appearance of Blood Vessels of Organs in Diabetes Mellitus. Deleted Journal. 2023;25:1–3. DOI: 10.62480/tjms.2023.vol25.pp1-3
  22. Liu R, Li L, Shao C, Cai H, Wang Z. The Impact of Diabetes on Vascular Disease: Progress from the Perspective of Epidemics and Treatments. Journal of Diabetes Research [Internet]. 2022;2022:1–17. DOI: 10.1155/2022/1531289
  23. Konda KK. High Blood Sugar Levels Over a Prolonged Period: Diabetes. Journal of Glycobiology. 2021;10(3):1-2.
  24. Li Z, Wu N, Wang J, Zhang Q. Roles of Endovascular Calyx Related Enzymes in Endothelial Dysfunction and Diabetic Vascular Complications. Frontiers in Pharmacology. 2020;11:590614. DOI: 10.3389/fphar.2020.590614
  25. Torimoto K, Okada Y, Tanaka Y. Type 2 Diabetes and Vascular Endothelial Dysfunction. Journal of UOEH. 2018;40(1):65–75. DOI: 10.7888/juoeh.40.65
  26. Xue C, Chen K, Gao Z, Bao T, Dong L, Zhao L, et al. Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction. Cell Communication and Signaling. 2023;21(1):298. DOI: 10.1186/s12964-022-01016-w
  27. Gora IM, Ciechanowska A, Ladyzynski P. NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes. Cells. 2021;10(2):314. DOI: 10.3390/cells10020314
  28. Van Den OM, Raterman HG, Nurmohamed MT, Simsek S. Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus. Mediators of Inflammation. 2010;2010:1–15. DOI: 10.1155/2010/792393

Published

2025-01-15

How to Cite

Khanenko , O., & Popovych , Y. (2025). Morphological alterations in the spleen of rats during late stages of experimental streptozotocin-induced diabetes mellitus. Морфологія / Morphologia / Morfologìâ, 18(4), 95–100. https://doi.org/10.26641/1997-9665.2024.4.95-100

Issue

Section

Статті